IHE Innovation Forum IV - Innovation and Economics

Innovation and Economics: Key People

Speaker Biographies

Keynote Speakers

Dr. Adam Elshaug

Dr Adam Elshaug (pronounced 'elshaw') is Sidney Sax Fellow with joint appointments in the School of Population Health and Clinical Practice at The University of Adelaide and at Harvard Medical School in Boston where he is based. Adam trained in clinical epidemiology and health services and policy research. He has focused in the area of refining use of low-value health services; evidentiary, clinical and policy barriers to reform and implementation. Increasingly referred to as disinvestment, this work involves the development and application of epidemiologic, economic, ethical and policy appraisals of existing, entrenched health care practices that are thought to be ineffective, less effective or inappropriately applied with a view to reducing these in favour of offering more effective health care services.

Dr Elshaug collaborates and consults with government health agencies (federal and provincial) in Australia and internationally (Spain, U.K., Canada) to advance methods and policy reform in this area. He is currently working with the Australian government to design and implement a formal disinvestment policy agenda within Medicare. Dr Elshaug serves as an Associate Editor for the journal BMC Health Services Research and has published in journals such as the BMJ, Quality and Safety in Health Care, and Medical Journal of Australia. He is chief investigator on two large disinvestment research grants, is recipient of numerous awards as a new or emerging researcher, and has received over 85 invitations to address conferences as well as government, academic, insurance and health technology assessment groups internationally.

Dr. Marvin Fritzler

Dr. Marvin Fritzler is Professor of Medicine at the University of Calgary where he holds the Arthritis Society Endowed Research Chair and is Director of the Advanced Diagnostics Laboratory. He served on the Scientific Advisory Board of the Centre for Environmental Health Sciences at the University of Montana and Chaired the Serology Committee of the International Union of Immunology Specialists and World Health Organization. He has served as a consultant to a number of diagnostic biotechnology companies including ImmunoConcepts (Sacramento), INOVA Inc. (San Diego), Immunex (Seattle); and Innogenetics (Belgium). He received the Distinguished Alumni Award and a number of Gold Star Letters of Excellence in Teaching from the University of Calgary. He served as the Associated Dean of Research and was Chair for the University Budget Committee for two terms. Prior to his appointment of Chair of ASRA, he was Chair of the Life Sciences Committee.


Dr. Stephen Duckett

Dr. Stephen Duckett has spent his professional life working in health care. As Alberta Health Services' new President and Chief Executive Officer (effective March 23, 2009). Dr. Duckett has more than 35 years of experience in health care.

Prior to coming to Alberta, Dr. Duckett was Chief Executive Officer of the Centre for Healthcare Improvement for Queensland Health in Australia. (Queensland occupies the north east of the Australian continent and is roughly triple the size of Alberta; Queensland health is the public provider with approximately 60,000 staff).

Before that, he was a professor of Health Policy and Dean of the Faculty of Health Sciences for 10 years at La Trobe University in Melbourne. He also chaired the board of a major public health provider, Alfred Health. Dr. Duckett's work in health care also includes two years with the Government of Australia as Secretary (equivalent to Deputy Minister) to the Department of Human Services and Health.

In 2006, Dr. Duckett received a Doctor of Business Administration in Higher Education Management from the University of Bath in the United Kingdom. That same year, he also received a Doctor of Science Award based on his publications from the University of New South Wales in Sydney, Australia. Dr. Duckett has a PhD in Health Administration from the University of New South Wales and a Bachelor of Economics (Economics and Pure Mathematics) from the Australian National University in Canberra, Australia.

Dr. Tom Feasby

Dr. Tom Feasby has been Dean of the Faculty of Medicine at the University of Calgary since 2007. Previously he was Vice-President of Academic Affairs at Capital Health and Associate Dean in the Faculty of Medicine at the University of Alberta. He is a practicing neurologist and a health services researcher, who studies the appropriateness of health care interventions. Dr. Feasby has been a long time member of the Institute of Health Economics Board and was recently appointed to serve on the Minister‘s Advisory Committee on Health. He completed his BSc and MD at the University of Manitoba, followed by a research fellowship at Institute of Neurology in London, England and professorships in neurology at the University of Western Ontario in London, Ont. From 1991 to 2003, while leading the U of C Faculty of Medicine's Department of Clinical Neurosciences, he was also head of the Calgary Health Region's regional Department of Clinical Neurosciences, where he assembled an internationally-recognized clinical neurosciences group.

His record of research excellence is reflected in more than 100 research publications in areas such as neurologic diseases and the appropriateness of health care interventions, his supervision of numerous graduate students, and his involvement in professional societies and organizations including the CIHR Institute of Health Services and Policy Research, the Canadian Academy of Health Sciences and the American Academy of Neurology.

Mr. Fred Horne

Mr. Fred Horne was elected to his first term as a Member of the Legislative Assembly for Edmonton-Rutherford on March 3, 2008. In addition to his regular duties as MLA, Mr. Horne serves as chair of the Standing Committee on Health, deputy chair of the Premier‘s Council on the Status of Persons with Disabilities and is a member of the Agenda and Priorities Committee, Private Members Business Committee, Legislative Offices Committee and the Select Special Chief Electoral Officer Search Committee. Prior to serving with the Legislative Assembly of Alberta, Mr. Horne worked as a health policy consultant for over 25 years, serving various government bodies and regional health authorities in addition to the public, private and not-for-profit sectors.

Throughout his career Mr. Horne led initiatives to improve access and quality in Canadian public health care and has worked extensively with the Conference Board of Canada, the Alberta government and the Mayo Clinic. An avid volunteer, Mr. Horne has served on numerous boards including: Alberta Mental Health Board, Athabasca University, Mediation and Restorative Justice Centre of Edmonton, Canadian Student Debating Federation. Additionally, Mr. Horne is a former debater and coached Team Canada at the World Schools Debating Championships. For his continued contributions to the development of debate and speech programs Mr. Horne received the Queen Elizabeth II Golden Jubilee Medal in 2002. Mr. Horne and his wife, Jennifer, have lived in Edmonton since 1992.

Dr. Bernard Prigent

Doctor Prigent is Vice-President and Medical Director of Pfizer Canada, the Canadian operation of Pfizer Inc., the world's leading research based pharmaceutical company.

Under his leadership, Pfizer Canada has become one of the top R&D investors within the Canadian Life Science Sector. These investments cover most aspects of pharmaceutical R&D from discovery to clinical trials as well as alliances with the biotech sector and partnerships with academic institutions, federal and provincial funding agencies.

His current activities within the Life Science Sector include:

  • Board Member of the Canadian Arthritis Network
  • Chair of the Scientific Committee of the Research Foundation of Rx&D
  • Member of the Strategic Advisory Committee of two C.E.C.R. initiatives: Center of Excellence in
  • Personalized Medicine and Prevention (CEPM) and Prevention of Epidemic Organ Failure (PROOF)
  • Chairman of the Strategic Orientation Committee of Quebec Consortium for Drug Discovery (CQDM)
  • Board Member of the Institute of Health Economics

Dr. Prigent joined Pfizer in 1995 and occupied positions of increasing responsibility before becoming Vice-President and Medical director in January 2001.

Dr. Raj Sherman

Dr. Sherman is Parliamentary Assistant to the Minister of Health and Wellness. He grew up in the B.C. interior, working as a young man in the lumber industry alongside many of his family members. After earning his MD from the University of Alberta, he went on to specialize in Family and Emergency Medicine. Later, he was elected President of the AMA's Section of Emergency Medicine and campaigned for action on emergency department wait times and overcrowding.

Dr. Sherman is a past member of the University of Alberta Senate and a clinical lecturer at the University of Alberta's Faculty of Medicine. He has been honoured with many awards over the years for his contributions in the community and in his profession. He continues to be a keynote speaker and panellist at national health conferences.